تفاصيل الوثيقة

نوع الوثيقة : مقال في مجلة دورية 
عنوان الوثيقة :
Prognostic Value of Proliferation Markers: Immunohistochemical Ki-67 Expression and Cytometric S-Phase Fraction of Women with Breast Cancer in Libya
Prognostic Value of Proliferation Markers: Immunohistochemical Ki-67 Expression and Cytometric S-Phase Fraction of Women with Breast Cancer in Libya
 
لغة الوثيقة : الانجليزية 
المستخلص : BACKGROUND: We evaluated the association of the immunohistochemical Ki-67 expression, and S-phase fraction with clinicopathological variables and patient outcome. PATIENTS AND METHODS: Histological samples from 100 primary Libyan breast carcinoma patients were retrospectively studied with monoclonal antibody to Ki-67. S-phase fraction was determined by DNA image cytometry. RESULTS: The median Ki-67 percentage for all tumors was 27.5%, ranging from 1 to 80% and the median S-phase fraction (SPF) was 11%, ranging from 0 to 62 %. Tumors with high Ki-67 expression were found in 76% of patients and with high SPF values in 56%. Ki-67 expression was more frequent in tumors with high SPF than low SPF. High Ki-67 and high SPF were associated with advanced stages, poor differentiation of tumors, positive lymph nodes, and distant metastasis. The Ki-67 was associated with hormone receptor negative tumors. The SPF was higher in young patients (<50 years) than in older patients. In the overall population (median follow-up 49 months), patients with high Ki-67 and high SPF had shorter survival time and predicted recurrence than patients with low Ki-67 and low SPF. In a Cox multivariate analysis, high SPF (p= 0.007), hormonal status (p= 0.001) and clinical stage (p=0.005) were independent predictors of disease-specific survival. The Ki-67 (p=0.065) in borderline significance proved to be independent predictor of disease-free survival. The SPF showed more statistically significance with a high grade of malignancy and survival time than Ki-67. CONCLUSIONS: The SPF value is useful cell proliferation marker to assess tumor prognosis. These markers may reflect the aggressive behavior of Libyan breast cancer and predict of the recurrence. It is therefore important to take these markers into consideration to select a high risk subgroup of the patients for intensive treatment. KEYWORDS: Ki-67 expression; Libyan female breast cancer; S-phase fraction; prognosis 
ردمد : 1837-9664 
اسم الدورية : Journal of Cancer 
المجلد : 3 
العدد : 1 
سنة النشر : 1433 هـ
2012 م
 
نوع المقالة : مقالة علمية 
تاريخ الاضافة على الموقع : Monday, March 14, 2016 

الباحثون

اسم الباحث (عربي)اسم الباحث (انجليزي)نوع الباحثالمرتبة العلميةالبريد الالكتروني
Eramah ErmiahErmiah, Eramah باحث رئيسي  
Abdelbaset BuhmeidaBuhmeida, Abdelbaset باحث مشارك  
Fathi AbdallaAbdalla, Fathi باحث مشارك  
Ben Romdhane KhaledKhaled, Ben Romdhane باحث مشارك  
Nada SalemSalem, Nada باحث مشارك  
Seppo PyrhönenPyrhönen, Seppo باحث مشارك  
Yrjö CollanCollan, Yrjö باحث مشارك  

الملفات

اسم الملفالنوعالوصف
 38524.pdf pdf 

الرجوع إلى صفحة الأبحاث